Paradigm Financial Statements From 2010 to 2025
| PDMI Stock | USD 0.0001 0.00 0.00% |
Check Paradigm Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Paradigm Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Paradigm financial statements analysis is a perfect complement when working with Paradigm Medical Valuation or Volatility modules.
Paradigm |
Paradigm Medical Ind Company Return On Asset Analysis
Paradigm Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Paradigm Medical Return On Asset | -0.14 |
Most of Paradigm Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Paradigm Medical Ind is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Paradigm Medical Ind has a Return On Asset of -0.1373. This is 98.43% lower than that of the Health Care Equipment & Supplies sector and 99.53% lower than that of the Health Care industry. The return on asset for all United States stocks is 1.93% lower than that of the firm.
Paradigm Medical Ind Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Paradigm Medical's current stock value. Our valuation model uses many indicators to compare Paradigm Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paradigm Medical competition to find correlations between indicators driving Paradigm Medical's intrinsic value. More Info.Paradigm Medical Ind is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Paradigm Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Paradigm Medical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Paradigm Medical Financial Statements
Investors use fundamental indicators, such as Paradigm Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Paradigm Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company was founded in 1989 and is based in Salt Lake City, Utah. Paradigm Medical operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 5 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Paradigm Pink Sheet
Paradigm Medical financial ratios help investors to determine whether Paradigm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paradigm with respect to the benefits of owning Paradigm Medical security.